Avantor, Inc. (NYSE: AVTR)
Health Care · Life Sciences Tools & Services · US
$15.67
+1.82% today · +15.7% 1Y
Avantor, Inc. (NYSE: AVTR) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $10.60B and employs 13,500 people.
Over the last twelve months the share price has gained 15.7%, trading between 7.27 and 16.38.
Tweenvest scores Avantor, Inc. across four factors: quality 55/100, value 53/100, growth 0/100. Its strongest factor is quality.
AVTR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.60B
- Revenue (TTM)
- $6.56B
- P/E
- —
- EPS
- -0.85
- Dividend yield
- —
- Beta (5Y)
- 0.94
- 52-week high
- $16.38
- 52-week low
- $7.27
- Avg volume (3M)
- —
- Shares outstanding
- 676.36M
- Employees
- 13,500
- Next earnings
- —
About Avantor, Inc.
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
- ISIN
- US05352A1007
- Founded
- 1904
- Listed since
- May 17, 2019
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ICON Public Limited CompanyNasdaqGS: ICLR | $12.67B | $164.17 | -0.20% |
| Genscript Biotech CorporationSEHK: 1548 | $12.32B | HK$42.40 | -3.02% |
| Bio-Techne CorporationNasdaqGS: TECH | $11.36B | $72.39 | -0.10% |
| Pharmaron Beijing Co., Ltd.SZSE: 300759 | $10.90B | CN¥43.11 | -4.14% |
| 10x Genomics, Inc.NasdaqGS: TXG | $10.51B | $79.76 | -1.10% |
| Repligen CorporationNasdaqGS: RGEN | $9.81B | $173.88 | +6.13% |
| Bio-Rad Laboratories, Inc.NYSE: BIO | $9.78B | $366.16 | +1.60% |
| Qiagen N.V.NYSE: QGEN | $9.38B | $45.38 | +1.91% |
Figures last refreshed Oct 11, 2026.